CHRISTINA SCHRACK: Open Payments
NPI 1861891566 · POTOMAC, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$166 in 7 payments from 5 companies in 2025. Trend: 2023 $210 · 2024 $297 · 2025 $166
Food & beverage: $166
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 1 | $63 |
| Novo Nordisk Inc | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Lilly USA, LLC | 1 | $18 |
| Verona Pharma, Inc. | 1 | $15 |
Products named: DAXXIFY, Wegovy, BREZTRI, MOUNJARO, Ohtuvayre.
Industry payments across MD — which companies pay providers there.
